Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
neotigason hart hylki 25 mg
teva b.v.* - acitretinum inn - hart hylki - 25 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
neotigason hart hylki 10 mg
teva b.v.* - acitretinum inn - hart hylki - 10 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
ropivacainhydrochlorid sintetica (ropivacaine sintetica 2 mg/ml stungulyf, lausn) innrennslislyf, lausn 2 mg/ml
sintetica gmbh - ropivacainum hýdróklóríð - innrennslislyf, lausn - 2 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
ropivacainhydrochlorid sintetica (ropivacaine sintetica 2 mg/ml stungulyf, lausn) stungulyf, lausn 2 mg/ml
sintetica gmbh - ropivacainum hýdróklóríð - stungulyf, lausn - 2 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
ropivacainhydrochlorid sintetica stungulyf, lausn 7,5 mg/ml
sintetica gmbh - ropivacainum hýdróklóríð - stungulyf, lausn - 7,5 mg/ml
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
neurobloc
sloan pharma s.a.r.l - botulinum eiturefni tegund b - torticollis - vöðvaslakandi lyf - neurobloc er ætlað til meðferðar á leghálsi (torticollis). sjá kafla 5. 1 fyrir gögn um virkni í sjúklingar móttækilegur / þola að botox tegund.
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
tachosil
corza medical gmbh - mannafíbrógen manna, trombín manna - hemostasis, skurðaðgerð - antihemorrhagics - tachosil is indicated in adults and children from 1 month of age for supportive treatment in surgery for improvement of haemostasis, to promote tissue sealing and for suture support in vascular surgery where standard techniques are insufficient. tachosil is indicated in adults for supportive sealing of the dura mater to prevent postoperative cerebrospinal leakage following neurological surgery (see section 5.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
botox stungulyfsstofn, lausn 100 allergan ein.
abbvie a/s - botulinum toxin type a - stungulyfsstofn, lausn - 100 allergan ein.